Please login to the form below

Not currently logged in
Email:
Password:

EASD: Study supports early use of Victoza

Novo Nordisk's GLP-1 analogue Victoza has greater benefit ifused early in the treatment of type 2 diabetes according to a study presentedat the European Association for the Study of Diabetes meeting

Novo Nordisk's GLP-1 analogue Victoza (liraglutide) has greater benefit if used early in the treatment of type 2 diabetes according to a study presented at the European Association for the Study of Diabetes (EASD) meeting in Lisbon, Portugal.

When used early in the treatment process, 72 per cent of patients treated with Victoza were able to achieve glycaemic control compared to 49 per cent who were treated late on. Glycaemic control was defined as the EASD target of HbA1c levels of less than 7 per cent.

Both results were significantly higher than compared to comparator groups in the trial: patients who had not received treatment before or previously only one oral anti-diabetic drug.

A separate study also presented at EASD showed that patients who switched from oral therapy with sitagliptin (marketed as Januvia by Merck) to once-daily injectable therapy with Victoza had an increase in overall treatment satisfaction based on the Diabetes Treatment Satisfaction Questionnaire at 52 and 78 weeks.

Study investigator, Professor Eduard Montanya from the Medical School of the University of Barcelona, Spain, said the increased satisfaction was partly due to greater weight loss associated with Victoza.

15th September 2011

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Star

Established in 2002, Star is a full service outsourcing and resourcing company that works with the best people and opportunities...

Latest intelligence

NEW EU DATA PROTECTION REGULATION POISED TO CHANGE DATA PRIVACY LANDSCAPE
NEW EU DATA PROTECTION REGULATION POISED TO CHANGE DATA PRIVACY LANDSCAPE The bold digital clock featured on the EUGDPR (EU General Data Protection Regulation)1 website indicates – to the second...
Health knowledge: Why is it so important?
Health knowledge plays an important role in population health, but by itself is rarely enough to prompt a change in the behaviours that cause the risks....
Personas: a top tool for personalising pharma marketing campaigns
Healthcare customers are calling for greater personalisation in care from providers. Here, we explain why personas are the top tool for ensuring your brand meets this need efficiently and effectively....

Infographics